Significance of lower respiratory tract cultures yielding Aspergillus spp. growth in a hospital without transplant patients

Revista Espanola de Quimioterapia

Volumn 23, Issue 4, 2010, Pages 190-195

  Lucena, Paloma ^a   Barberán, José ^a   Eroles, Guillermo ^b   Granizo, Juan José ^c   Giménez, María José ^d   Mir, Nuria ^e   Aguilar, Lorenzo ^d   Prieto, José ^d  

^a HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^b HOSPITAL SEVERO OCHOA   (Spain)

^c Grana Datos SL   (Spain)

^d SCHOOL OF MEDICINE   (Spain)

^e PFIZER INC   (United States)

Author keywords

Aspergillosis; Aspergillus fumigatus; Chronic obstructive pulmonary disease; Colonization; Invasive disease

Indexed keywords

AMPHOTERICIN; CASPOFUNGIN; CORTICOSTEROID; ITRACONAZOLE; VORICONAZOLE;

ADULT; AGED; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; BRONCHUS SECRETION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CORTICOSTEROID THERAPY; EMPHYSEMA; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HOSPITAL PATIENT; HUMAN; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; RETROSPECTIVE STUDY; SPUTUM CULTURE;

ADRENAL CORTEX HORMONES; AGED; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PULMONARY ASPERGILLOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RESPIRATORY TRACT INFECTIONS;

EID: 78651359216     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, León C, Alvarez-Lerma F, Nolla-Salas J, et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005;9:R191-9.
2. Soubani AO, Khanchandani G, Ahmed HP. Clinical significance of lower respiratory tract Aspergillus culture in elderly hospitalized patients. Eur J Clin Microbiol Infect Dis 2004;23:491-4.
3. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007;30:782-800.
4. Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005;43 Suppl 1:S207-38.
5. Perfect JR, Cox GM, Lee JY, Kauffman CA, de Repentigny L, Chapman SW et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001;33:1824-3.
6. Vandewoude KH, Blot SI, Depuydt P, Benoit D, Temmerman W, Colardyn F et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 2006;10:R31.
7. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
8. Bulpa PA, Dive AM, Garrino MG, Delos MA, Gonzalez MR, Evrard PA et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care?. Intensive Care Med 2001;27:59-67.
9. Conesa D, Rello J, Vallés J, Mariscal D, Ferreres JC. Invasive aspergillosis: a life-threatening complication of short-term steroid treatment. Ann Pharmacother 1995;29:1235-7.
10. Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998;26:1473-5.
11. Nalesnik MA, Myerowitz RL, Jenkins R, Lenkey J, Herbert D. Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 1980;11:370-6.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
13. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-51.
14. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
15. Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock 1999;11:153-9.
16. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993;61:4870-7. (Pubitemid 23320547)
17. Denning DW. Aspergillus in "nonimmunocompromised" critically ill patients. Am J Respir Crit Care Med 2004;170:580-1.
18. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-15. (Pubitemid 34851833)